VICTORIA, BC, April 16 /CNW/ - Aspreva Pharmaceuticals Corporation
(NASDAQ: ASPV; TSX: ASV), a pharmaceutical company focused on increasing the
pool of evidence-based medicines available for patients living with less
common diseases, announced today that the company will release financial and
business results for the first quarter ending March 31, 2007 on Wednesday, May
The Company will hold a conference call and webcast beginning at 2:00
p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these results.
North America (toll free): 1-800-510-9661
Enter passcode: 21957711
The call will be available for replay until Wednesday, May 9th, by
calling 1-888-286-8010 (North America) or 1-617-801-6888 (International) and
entering the pass code 16213778.
A live webcast will also be available to all interested parties on
Aspreva's website: www.aspreva.com. Please click on the "Webcasts and Events"
link under the Investors section of Aspreva's website. A replay of the webcast
will be available until the Company's second quarter 2007 conference call.
About Aspreva Pharmaceuticals
Aspreva is focused on identifying, developing, and, upon approval,
commercializing, high-impact therapies for patients suffering from diseases
that have historically been underserved. Aspreva common stock is traded on the
NASDAQ Global Select Market under the trading symbol "ASPV" and on the Toronto
Stock Exchange under the trading symbol "ASV".
For further information:
For further information: Sage Baker, VP, Investor Relations & Corporate
Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270,